小细胞肺癌的二线治疗选择:道尽头的光
1Oncology Department, Istituto Ospedaliero Fondazione Poliambulanza, Via Leonida Bissolati 57, 25124 Brescia, Italy.
Cancers
|January 23, 2024
概括
小细胞肺癌 (SCLC) 的二线治疗面临挑战,因为选择有限,结果令人失望. 研究探索新型疗法,如抗PD-1/PD-L1抗体和DLL3抑制剂,以改善患者的反应.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 小细胞肺癌 (SCLC) 是一种侵略性的亚型,大多数患者被诊断为晚期疾病和高复发率.
- 目前的一线化疗免疫治疗是标准的,但SCLC的二线治疗选择有限,结果不佳.
研究的目的:
- 审查目前对SCLC的二线治疗策略的现状.
- 讨论新兴疗法的临床疗效和SCLC管理的未来研究方向.
主要方法:
- 对SCLC当前和试验中的二线治疗方法的文献综述.
- 专注于针对PD-1/PD-L1和DLL3的免疫疗法,以及像Tarlatamab这样的新药.
主要成果:
- 在SCLC的第二线治疗结果与第一线治疗后的无进展间隔密切相关.
- 新兴的目标包括抗PD-1/PD-L1抗体和DLL3,Tarlatamab在临床研究中显示出有希望的结果.
结论:
- 对于SCLC来说,急需更有效的二线治疗方法.
- 针对新型免疫和细胞途径的研究疗法有可能改善复发性SCLC的结果.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
